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Background 
• According to the NICE guidance, children under the age 
of 16 are excluded from the national guidance on 
medicines reconciliation upon hospital admission.1 
 
• A study, suggested that potential adverse drug reactions 
are not uncommon in children and may be 3 times more 
common in paediatrics compared to  adults.2 
 
• Preliminary work showed that the absence of medicines 
reconciliation on admission to hospital for children 
increases their exposure to risk from discrepancies.3 
Aims and objectives 
Primary 
• Use medicines reconciliation to identify if 
discrepancies occur upon hospital 
admission across four hospitals  
 
Secondary 
• Clinically assess for potential harm to 
discrepancies that were identified 
 
Population targeted  
• Paediatrics (aged 0 – 18 years) on long 
term medication.   
 
 
 
Method – Study Design 
• Prospective observational study across 4 NHS hospitals in 
Birmingham, London, Leeds and North Staffordshire. 
 
• Registered with R&D office, NHS ethical approval not required 
 
• Setting 
• Paediatric wards for 2 sites/Paediatric hospital for the other sites 
 
• Inclusion criteria 
• Patients aged 0 – 18 years old on long term medication 
• Patients admitted into hospital via A&E and home 
 
• Exclusion criteria 
• Patients transferred from other hospitals 
• Patients transferred from the same ward 
• Patients on PICU 
 
• Sample size 
• 240 patients consecutively admitted to the hospital ward during the 
study period January – May 2011 (Approximately 60 per site) 
 
 
 
 
 
 Method – Data Collection      
• Data was collected by pharmacists across the 4 sites – all 
pharmacists  received training 
• Standardised paper data collection forms were used to collect 
information from the following: -  
– Caregiver interview 
– GP (via telephone or fax) 
– Patient Own Drugs 
– Drug chart (Admission medication orders) 
• Medication name, Dose, Directions were recorded for each 
source of information  
• The pharmacists would make their own list of what the patient’s 
recommended therapy would be based on the information 
found.   
 
 
 
 
 
 
Method – Data collection (2) 
• Data from all sites were transferred onto an 
excel spreadsheet and combined 
 
• Discrepancies between the GP record and 
Drug chart at admission were identified and 
marked as intentional or unintentional after 
discussion with prescriber 
 
• An expert panel screened through the 
unintentional discrepancies  
 
 
Method – Clinical Assessment 
 
• Panel of 5 Healthcare professionals met together and 
were presented with each unintended discrepancy which 
was discussed. 
 
• A score would be agreed by discussion until a 
consensus was met.  Judges were not given the 
opportunity to record their own scores 
 
• Scores were given based on the likelihood of causing 
potential discomfort or clinical deterioration: -   
– Class 1 Unlikely 
– Class 2 Moderate 
– Class 3 Severe 
 
• Scoring had been used in adult studies4 and also adopted by a 
Canadian paediatric study5 
 
 
Results (Demographics) 
• Over the 5 month data collection period 244 
patients were seen and 1004 medication 
regimens were identified. 
 (60 patients seen in Birmingham/Leeds, 61 at 
North Staffordshire, 63 in London) 
• Age range 1 month – 16 years of age (median 5 
years, interquartile range 1.5 years to 11 years) 
• Majority of patients from General Paediatric 
medicine 
 
 
 
Results (Data) 
• 1004 medication regimens (n = 244) were 
identified 
– 588 Discrepancies were identified (n = 205 
patients) 
– 316 of which were initially identified as 
unintentional (n = 135) 
– 209 were true unintentional discrepancies (n 
= 109 patients)  
 
Results – Clinical 
Assessment 
• A panel of 5 healthcare professionals (2 
registrars, 1 nurse, 2 senior pharmacists) 
discussed the 209 discrepancies 
• 189 were classifiable.   
189 were classified (100 patients) 
• Class 1 discrepancies (unlikely) = 57 (30%)  40 patients (40%) 
• Class 2 discrepancies (moderate) = 89 (47%)  62 patients (62%) 
• Class 3 discrepancies (Severe) = 43 (23%)  28 patients (28%) 
 
 – *20 unintended discrepancies (18 patients) were cases where 
the deviation from the GP record would have been the right 
thing to do.  
 
Limitations 
• The method of comparing the GP and Drug 
Chart did not consider the scenario where 
deviating would have been beneficial 
 
• The clinical assessment method assessed the 
discrepancy per medication basis 
 
• The research captured what was on the GPs 
record but did not look into adherence.   
Conclusions 
• Medicines reconciliation used has 
identified that medication discrepancies do 
occur when a child is admitted to hospital 
 
 
 
• The unintended discrepancies have been 
found to be potentially harmful if 
unresolved in 70% of cases  
 
 
 
 
 
 
 
Future work 
• Development of a pharmacist led – medicines 
reconciliation intervention for children upon 
hospital admission 
 
• Exploring post hospital discharge medicines 
reconciliation in children 
 
 
Key Messages 
• Children who are admitted to hospital who are 
on long term medication 
 
– Do experience medication discrepancies at this point 
of transition which have a clinical consequence if not 
rectified 
 
– Medicines reconciliation is required in this group of 
patients in order to resolve these discrepancies.  This 
may not be as straightforward as contacting the GP 
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